Latest ANIP reports update at 2024-02-29: 2023 ∙ 2022 ∙ 2021

ANI Pharmaceuticals ANIP

$ 65.88 0.4%

ANI Pharmaceuticals Balance Sheet 2011-2024 | ANIP

Annual Balance Sheet ANI Pharmaceuticals

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	65.3 M	238 M	187 M	178 M	123 M	140 M	170 M	93.3 M	-41.3 M	-58.3 M	-11.1 M	-26.9 M	-39.9 M
Long Term Debt	285 M	286 M	287 M	172 M	176 M	67.3 M	198 M	121 M	113 M	111 M	-	-	17.3 M
Long Term Debt Current	1.56 M	850 K	850 K	13.2 M	9.94 M	3.26 M	3.35 M	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	182 M	67.8 M	198 M	121 M	113 M	111 M	-	-	17.3 M
Total Current Liabilities	145 M	99.4 M	87.5 M	78.6 M	61.7 M	166 M	39.2 M	31.9 M	11.8 M	13.2 M	3.54 M	10.6 M	7.23 M
Total Liabilities	447 M	422 M	413 M	265 M	244 M	233 M	237 M	153 M	125 M	124 M	3.54 M	10.6 M	24.6 M
Deferred Revenue	-	-	-	80 K	451 K	711 K	-	-	-	-	47 K	-	-
Retained Earnings	-80.1 M	-97.3 M	-47.8 M	-4.97 M	17.6 M	11.5 M	-4.01 M	-2.92 M	-4.35 M	-19.7 M	-48.5 M	-245 M	-217 M
Total Assets	904 M	760 M	772 M	461 M	457 M	431 M	412 M	323 M	285 M	264 M	44.5 M	38.8 M	62.4 M
Cash and Cash Equivalents	221 M	48.2 M	100 M	7.86 M	62.3 M	43 M	31.1 M	27.4 M	155 M	169 M	11.1 M	11 K	57.2 M
Book Value	458 M	339 M	359 M	196 M	213 M	197 M	175 M	170 M	160 M	140 M	41 M	28.2 M	37.8 M
Total Shareholders Equity	433 M	314 M	334 M	196 M	213 M	197 M	175 M	170 M	160 M	140 M	41 M	-42.7 M	37.8 M

All numbers in USD currency

Quarterly Balance Sheet ANI Pharmaceuticals

	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	285 M	285 M	285 M	286 M	286 M	286 M	286 M	287 M	186 M	190 M	169 M	172 M	172 M	172 M	172 M	176 M	176 M	176 M	176 M	67.3 M	67.3 M	67.3 M	67.3 M	69.9 M	69.9 M	69.9 M	69.9 M	-	121 M	121 M	121 M	113 M	113 M	113 M	113 M	107 M	111 M	111 M	111 M	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	435 M	425 M	426 M	422 M	402 M	414 M	399 M	413 M	279 M	288 M	260 M	265 M	265 M	265 M	265 M	244 M	244 M	244 M	244 M	233 M	233 M	233 M	233 M	237 M	237 M	237 M	237 M	153 M	153 M	153 M	153 M	125 M	125 M	125 M	125 M	120 M	124 M	124 M	124 M	3.54 M	-	-	9.33 M	10.6 M	10.9 M	16.4 M	16.6 M	24.6 M	24.6 M	24.6 M	24.6 M
Deferred Revenue	-	-	-	-	-	-	116 K	87 K	62 K	62 K	62 K	80 K	80 K	80 K	318 K	451 K	451 K	558 K	624 K	711 K	735 K	711 K	711 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-80.9 M	-90.4 M	-96.3 M	-97.3 M	-92.6 M	-83.6 M	-68.3 M	-47.8 M	-23.4 M	-19 M	-4.89 M	-4.97 M	-4.97 M	-4.97 M	-4.97 M	17.6 M	17.6 M	17.6 M	17.6 M	11.5 M	11.5 M	11.5 M	11.5 M	-4.01 M	-4.01 M	-4.01 M	-4.01 M	-2.92 M	-2.92 M	-2.92 M	-2.92 M	-4.35 M	-4.35 M	-4.35 M	-4.35 M	-19.7 M	-19.7 M	-19.7 M	-19.7 M	-48.5 M	-48.5 M	-48.5 M	-48.5 M	-43.8 M	-43.8 M	-43.8 M	-245 M	-217 M	-217 M	-217 M	-217 M
Total Assets	890 M	859 M	765 M	760 M	739 M	751 M	745 M	772 M	470 M	480 M	464 M	461 M	461 M	461 M	461 M	457 M	457 M	457 M	457 M	431 M	431 M	431 M	431 M	412 M	412 M	412 M	412 M	323 M	323 M	323 M	323 M	285 M	285 M	285 M	285 M	260 M	264 M	264 M	264 M	44.5 M	44.5 M	44.5 M	44.5 M	13.7 M	13.7 M	13.7 M	38.8 M	62.4 M	62.4 M	62.4 M	62.4 M
Cash and Cash Equivalents	193 M	162 M	67.8 M	48.2 M	56.3 M	63.4 M	76.9 M	100 M	15.3 M	24.3 M	25.1 M	7.86 M	7.86 M	7.86 M	7.86 M	62.3 M	62.3 M	62.3 M	62.3 M	43 M	43 M	43 M	43 M	31.1 M	31.1 M	31.1 M	31.1 M	27.4 M	27.4 M	27.4 M	27.4 M	155 M	155 M	155 M	155 M	169 M	169 M	169 M	169 M	11.1 M	11.1 M	11.1 M	11.1 M	11 K	11 K	11 K	34.8 M	-	57.2 M	57.2 M	57.2 M
Book Value	455 M	434 M	339 M	339 M	337 M	337 M	346 M	359 M	191 M	192 M	204 M	196 M	196 M	196 M	196 M	213 M	213 M	213 M	213 M	197 M	197 M	197 M	197 M	175 M	175 M	175 M	175 M	170 M	170 M	170 M	170 M	160 M	160 M	160 M	160 M	140 M	140 M	140 M	140 M	41 M	44.5 M	44.5 M	35.2 M	3.15 M	2.83 M	-2.63 M	22.2 M	37.8 M	37.8 M	37.8 M	37.8 M
Total Shareholders Equity	430 M	410 M	315 M	314 M	312 M	312 M	321 M	334 M	191 M	192 M	204 M	196 M	196 M	196 M	196 M	213 M	213 M	213 M	213 M	197 M	197 M	197 M	197 M	175 M	175 M	175 M	175 M	170 M	170 M	170 M	170 M	160 M	160 M	160 M	160 M	140 M	140 M	140 M	140 M	41 M	41 M	41 M	41 M	-42.7 M	-42.7 M	-42.7 M	28.2 M	-34.3 M	37.8 M	37.8 M	37.8 M

All numbers in USD currency